Q&A: Study findings provide details on adjusting epilepsy drugs in pregnancy

Epilepsy clinicians who also specialize in women’s health and work with women during the perinatal period can consult with a new set of data to provide a road map for adjusting antiseizure medications.
The Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) study, conducted between 2016 and 2020, followed almost 300 women with epilepsy and their children from pregnancy through age 6 years.
Researchers at the University of Pittsburgh School of Medicine and Medical Center, as well as 20 other academic medical centers, logged instances of real-world epilepsy care








